000 | 01788 a2200517 4500 | ||
---|---|---|---|
005 | 20250516203122.0 | ||
264 | 0 | _c20150511 | |
008 | 201505s 0 0 eng d | ||
022 | _a1178-2013 | ||
024 | 7 |
_a10.2147/IJN.S58626 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Zhengni | |
245 | 0 | 0 |
_aCarbon nanotubes as VEGF carriers to improve the early vascularization of porcine small intestinal submucosa in abdominal wall defect repair. _h[electronic resource] |
260 |
_bInternational journal of nanomedicine _c2014 |
||
300 |
_a1275-86 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAbdominal Wall _xblood supply |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiocompatible Materials |
650 | 0 | 4 | _aBiomechanical Phenomena |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xetiology |
650 | 0 | 4 |
_aIntestinal Mucosa _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMaterials Testing |
650 | 0 | 4 | _aNanomedicine |
650 | 0 | 4 |
_aNanotubes, Carbon _xadverse effects |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSus scrofa |
650 | 0 | 4 |
_aTissue Scaffolds _xadverse effects |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xadministration & dosage |
650 | 0 | 4 |
_aWound Healing _xdrug effects |
700 | 1 | _aFeng, Xueyi | |
700 | 1 | _aWang, Huichun | |
700 | 1 | _aMa, Jun | |
700 | 1 | _aLiu, Wei | |
700 | 1 | _aCui, Daxiang | |
700 | 1 | _aGu, Yan | |
700 | 1 | _aTang, Rui | |
773 | 0 |
_tInternational journal of nanomedicine _gvol. 9 _gp. 1275-86 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/IJN.S58626 _zAvailable from publisher's website |
999 |
_c23657844 _d23657844 |